The peptide influences both endothelial nitric oxide synthase (eNOS), which produces the beneficial, vasodilating form of nitric oxide, and inducible nitric oxide synthase (iNOS), which can produce excessive amounts that contribute to inflammation and tissue damage
Track your progress: Use a journal or app to note how you feel, your energy levels, and your appetite changes
This combination approach targets two different aspects of the same problem, potentially yielding better outcomes than either peptide alone
It is classified as a Category 2 bulk drug substance by the FDA, which restricts its availability through compounding pharmacies
Ligament damage ACL/MCL sprains Ankle sprains Wrist ligament injuries Ligaments have poor blood supply naturally
Lab Testing Notes Third-party verified via HPLC (purity ?99%) and Mass Spectrometry